HomeCompareMEDS vs YUM

MEDS vs YUM: Dividend Comparison 2026

MEDS yields 125.16% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDS wins by $10.26M in total portfolio value
10 years
MEDS
MEDS
● Live price
125.16%
Share price
$7.59
Annual div
$9.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.37M
Annual income
$4,031,270.48
Full MEDS calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — MEDS vs YUM

📍 MEDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDSYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDS + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDS pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDS
Annual income on $10K today (after 15% tax)
$10,639.00/yr
After 10yr DRIP, annual income (after tax)
$3,426,579.91/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, MEDS beats the other by $3,392,616.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDS + YUM for your $10,000?

MEDS: 50%YUM: 50%
100% YUM50/50100% MEDS
Portfolio after 10yr
$5.24M
Annual income
$2,035,613.90/yr
Blended yield
38.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

MEDS
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-3.0
Piotroski
5/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDS buys
0
YUM buys
7
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$YUM▲ Buy$1,001 - $15,0002025-09-05
Lisa McClain🏢 House$YUM▲ Buy$1,001 - $15,0002025-06-24
Gilbert Cisneros🏢 House$YUM▼ Sell$1,001 - $15,0002025-05-30
Gilbert Cisneros🏢 House$YUM▼ Sell$1,001 - $15,0002025-05-30
Rob Bresnahan🏢 House$YUM▼ Sell$1,001 - $15,0002025-05-15
James E Hon Banks🏛 Senate$YUM▼ Sell$1,001 - $15,0002025-02-18
James E Hon Banks🏛 Senate$YUM▼ Sell$1,001 - $15,0002025-02-18
James E Hon Banks🏛 Senate$YUM▼ Sell$1,001 - $15,0002025-02-18
James E Hon Banks🏢 House$YUM▼ Sell$1,001 - $15,0002025-02-18
James E Hon Banks🏢 House$YUM▲ Buy$1,001 - $15,0002024-08-08
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDSYUM
Forward yield125.16%1.85%
Annual dividend / share$9.50$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$10.37M$107.0K
Annual income after 10y$4,031,270.48$39,957.33
Total dividends collected$9.46M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold

Year-by-year: MEDS vs YUM ($10,000, DRIP)

YearMEDS PortfolioMEDS Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$23,216$12,516.47$10,980$280.44+$12.2KMEDS
2$51,999$27,157.78$12,185$435.72+$39.8KMEDS
3$112,487$56,847.66$13,722$684.14+$98.8KMEDS
4$235,291$114,929.87$15,773$1,090.14+$219.5KMEDS
5$476,435$224,673.57$18,650$1,773.02+$457.8KMEDS
6$934,959$425,173.83$22,921$2,966.37+$912.0KMEDS
7$1,780,186$779,779.50$29,685$5,158.69+$1.75MMEDS
8$3,292,387$1,387,588.61$41,216$9,453.02+$3.25MMEDS
9$5,921,260$2,398,405.13$62,672$18,571.31+$5.86MMEDS
10$10,367,018$4,031,270.48$107,016$39,957.33+$10.26MMEDS

MEDS vs YUM: Complete Analysis 2026

MEDSStock

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Full MEDS Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this MEDS vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDS vs SCHDMEDS vs JEPIMEDS vs OMEDS vs KOMEDS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.